Show simple item record

dc.contributor.authorSilverman, Howard D
dc.contributor.authorGrunauer, Michelle
dc.date.accessioned2020-05-18T22:35:27Z
dc.date.available2020-05-18T22:35:27Z
dc.date.issued2020-01-28
dc.identifier.citationSilverman, H. D., & Grunauer, M. (2020). The clinician's role in promoting resiliency for individuals and families with growth anomalies. Growth Hormone & IGF Research, 51, 34-37.en_US
dc.identifier.issn1096-6374
dc.identifier.pmid32018120
dc.identifier.doi10.1016/j.ghir.2020.01.004
dc.identifier.urihttp://hdl.handle.net/10150/641335
dc.description.abstractSome recent clinic and population-based studies suggest that severe short stature is not associated with significant behavioral and psychological problems, however collectively studies on this topic are variable and frequently contradictory. In light of these contradictory sources, it is important to recognize that there may be some children for whom growth failure is disabling. Many of such children can respond to counseling and support, but there may be occasions in which therapy can be recommended. Resiliency can be defined as a pattern of positive adaptation in the context of past or present adversity with resiliency in childhood defined as typical development in the face of adverse circumstances that propel others to deleterious outcomes. Several strategies for promoting resilience in short stature patients and their families include 1) conducting a comprehensive psychosocial assessment; 2) recommending psychological strategies to directly address predictable social challenges associated with short stature; 3) discouraging the expectation that taller stature is associated with improvement in quality of life and; 4) discussing treatment efficacy in terms of the degree of certainty and magnitude of effects. Recognizing time constraints in clinical settings, these approaches can be carried out across multiple visits. Being aware of, honoring, and addressing factors the parent and patient use in making their treatment decisions has the potential to promote resiliency in patients and families. This approach to clinical care can serve to promote resiliency in clinicians as well.en_US
dc.language.isoenen_US
dc.publisherELSEVIERen_US
dc.rightsCopyright © 2020 Elsevier Ltd. All rights reserved.en_US
dc.rights.urihttp://rightsstatements.org/vocab/InC/1.0/en_US
dc.titleThe clinician's role in promoting resiliency for individuals and families with growth anomaliesen_US
dc.typeArticleen_US
dc.identifier.eissn1532-2238
dc.contributor.departmentUniv Arizona, Coll Med Phoenixen_US
dc.identifier.journalGROWTH HORMONE & IGF RESEARCHen_US
dc.description.note12 month embargo; available online 28 January 2020en_US
dc.description.collectioninformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.en_US
dc.eprint.versionFinal accepted manuscripten_US
dc.source.journaltitleGrowth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society
dc.source.volume51
dc.source.beginpage34
dc.source.endpage37
dc.source.countryScotland


Files in this item

Thumbnail
Name:
2020-01-08 GHIR-D-19-00088R1 ...
Size:
411.8Kb
Format:
PDF
Description:
Final Accepted Manuscript

This item appears in the following Collection(s)

Show simple item record